Mass spectrometric analysis of a cyclic 7,8-butanoguanine adduct of N-nitrosopyrrolidine: comparison to other N-nitrosopyrrolidine adducts in rat hepatic DNA.

The well established rat hepatocarcinogen N-nitrosopyrrolidine (NPYR, 1) requires metabolic activation to DNA adducts to express its carcinogenic activity. Among the NPYR-DNA adducts that have been identified, the cyclic 7,8-butanoguanine adduct 2-amino-6,7,8,9-tetrahydro-9-hydroxypyrido[2,1-f]purine-4(3H)-one (6) has been quantified using moderately sensitive methods, but its levels have never been compared to those of other DNA adducts of NPYR in rat hepatic DNA. Therefore, in this study, we developed a sensitive new LC-ESI-MS/MS-SRM method for the quantitation of adduct 6 and compared its levels to those of several other NPYR-DNA adducts formed by different mechanisms. The new method was shown to be accurate and precise, with good recoveries and low fmol detection limits. Rats were treated with NPYR by gavage at doses of 46, 92, or 184 mg/kg body weight and sacrificed 16 h later. Hepatic DNA was isolated and analyzed for NPYR-DNA adducts. Adduct 6 was by far the most prevalent, with levels ranging from about 900-3000 micromol/mol Gua and responsive to dose. Levels of adducts formed from crotonaldehyde, a metabolite of NPYR, were about 0.2-0.9 micromol/mol dGuo, while those of adducts resulting from reaction with DNA of tetrahydrofuranyl-like intermediates were in the range of 0.01-4 micromol/mol deoxyribonucleoside. The results of this study demonstrate that, among typical NPYR-DNA adducts, adduct 6 is easily the most abundant in hepatic DNA. Since previous studies have shown that it can be detected in the urine of NPYR-treated rats, the results suggest that it is a potential candidate as a biomarker for assessing human exposure to and metabolic activation of NPYR.

[1]  S. Hecht,et al.  Identification of adducts formed in the reaction of alpha-acetoxy-N-nitrosopyrrolidine with deoxyribonucleosides and DNA. , 2007, Chemical research in toxicology.

[2]  A. Nishikawa,et al.  Analysis of adducts in hepatic DNA of rats treated with N-nitrosopyrrolidine. , 2007, Chemical research in toxicology.

[3]  S. Hrudey,et al.  Characterization of new nitrosamines in drinking water using liquid chromatography tandem mass spectrometry. , 2006, Environmental science & technology.

[4]  S. Hecht,et al.  Analysis of crotonaldehyde- and acetaldehyde-derived 1,n(2)-propanodeoxyguanosine adducts in DNA from human tissues using liquid chromatography electrospray ionization tandem mass spectrometry. , 2006, Chemical research in toxicology.

[5]  P. Di Mascio,et al.  2'-deoxyguanosine, 2'-deoxycytidine, and 2'-deoxyadenosine adducts resulting from the reaction of tetrahydrofuran with DNA bases. , 2006, Chemical research in toxicology.

[6]  J. Fishbein,et al.  The structure of DNA dictates purine atom site selectivity in alkylation by primary diazonium ions. , 2005, Chemical research in toxicology.

[7]  K. Kanki,et al.  In vivo mutational analysis of liver DNA in gpt delta transgenic rats treated with the hepatocarcinogens N‐nitrosopyrrolidine, 2‐amino‐3‐methylimidazo[4,5‐f]quinoline, and di(2‐ethylhexyl)phthalate , 2005, Molecular carcinogenesis.

[8]  R. Carchman,et al.  Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. , 2004, Toxicology.

[9]  M. Müller,et al.  Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten , 2004, Zeitschrift für Krebsforschung.

[10]  S. Hecht,et al.  A Schiff base is a major DNA adduct of crotonaldehyde. , 2001, Chemical research in toxicology.

[11]  S. Hecht,et al.  Reactions of alpha-acetoxy-N-nitrosopyrrolidine with deoxyguanosine and DNA. , 2001, Chemical research in toxicology.

[12]  S. Hecht,et al.  Identification of paraldol-deoxyguanosine adducts in DNA reacted with crotonaldehyde. , 2000, Chemical research in toxicology.

[13]  S. Hecht,et al.  Lactols in Hydrolysates of DNA Treated with α-Acetoxy-N-nitrosopyrrolidine or Crotonaldehyde , 1998 .

[14]  S. Hecht,et al.  A cyclic N7,C-8 guanine adduct of N-nitrosopyrrolidine (NPYR): formation in nucleic acids and excretion in the urine of NPYR-treated rats. , 1997, Chemical research in toxicology.

[15]  E. Zeiger,et al.  Handbook of Carcinogenic Potency and Genotoxicity Databases , 1996 .

[16]  G. Hageman,et al.  Nitrate contamination of drinking water: relationship with HPRT variant frequency in lymphocyte DNA and urinary excretion of N-nitrosamines. , 1996, Environmental health perspectives.

[17]  A. Schally,et al.  High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Hecht,et al.  Formation of N2-tetrahydrofuranyl and N2-tetrahydropyranyl adducts in the reactions of alpha-acetoxy-N-nitrosopyrrolidine and alpha-acetoxy-N-nitrosopiperidine with DNA. , 1995, Chemical research in toxicology.

[19]  S. Hecht,et al.  Reactions of alpha-acetoxy-N-nitrosopyrrolidine and alpha-acetoxy-N-nitrosopiperidine with deoxyguanosine: formation of N2-tetrahydrofuranyl and N2-tetrahydropyranyl adducts. , 1995, Chemical research in toxicology.

[20]  B. Spiegelhalder,et al.  Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patients. , 1994, Carcinogenesis.

[21]  S. Hecht,et al.  Formation of 7-(4-oxobutyl)guanine in hepatic DNA of rats treated with N-nitrosopyrrolidine. , 1992, Carcinogenesis.

[22]  William Lijinsky,et al.  Chemistry and Biology of N-Nitroso Compounds , 1992 .

[23]  T. Kälble,et al.  Secondary amine precursors to nitrosamines in human saliva, gastric juice, blood, urine and faeces. , 1992, Carcinogenesis.

[24]  R. Peto,et al.  Chronic nitrosamine ingestion in 1040 rodents: the effect of the choice of nitrosamine, the species studied, and the age of starting exposure. , 1991, Cancer research.

[25]  J. Chawla,et al.  Increased urinary nitrosamine excretion in paraplegic patients. , 1991, Carcinogenesis.

[26]  R. C. Shank,et al.  Formation and persistence of a DNA adduct in rodents treated with N-nitrosopyrrolidine. , 1991, Carcinogenesis.

[27]  B. Spiegelhalder,et al.  Mean daily intake of volatile N-nitrosamines from foods and beverages in West Germany in 1989-1990. , 1991, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[28]  S. Hecht,et al.  Formation of acyclic and cyclic guanine adducts in DNA reacted with alpha-acetoxy-N-nitrosopyrrolidine. , 1989, Chemical research in toxicology.

[29]  S. Hecht,et al.  Detection of cyclic 1,N2-propanodeoxyguanosine adducts in DNA of rats treated with N-nitrosopyrrolidine and mice treated with crotonaldehyde. , 1989, Carcinogenesis.

[30]  S. Hecht,et al.  Detection of exocyclic guanine adducts in hydrolysates of hepatic DNA of rats treated with N-nitrosopyrrolidine and in calf thymus DNA reacted with alpha-acetoxy-N-nitrosopyrrolidine. , 1989, Cancer research.

[31]  H. Bartsch,et al.  Human exposure to endogenous N-nitroso compounds: quantitative estimates in subjects at high risk for cancer of the oral cavity, oesophagus, stomach and urinary bladder. , 1989, Cancer surveys.

[32]  D. Grunberger,et al.  Molecular Biology of Mutagens and Carcinogens , 1983, Springer US.

[33]  S. Hecht,et al.  Formation of cyclic 1,N2--adducts by reaction of deoxyguanosine with alpha-acetoxy-N-nitrosopyrrolidine, 4-(carbethoxynitrosamino)butanal, or crotonaldehyde. , 1983, Cancer research.

[34]  William N. Rom,et al.  Environmental and occupational medicine , 1983 .

[35]  R. C. Shank,et al.  Evidence for DNA adducts in rat liver after administration of N-nitrosopyrrolidine. , 1982, Biochemical and biophysical research communications.

[36]  S. Hecht,et al.  The Metabolism of Cyclic Nitrosamines , 1981 .

[37]  M. Ehrlich,et al.  Quantitative reversed-phase high performance liquid chromatographic determination of major and modified deoxyribonucleosides in DNA. , 1980, Nucleic acids research.